$ADAG Balance Sheet | Understand Stock

$ADAG

$2.49 +$0.08 (3.32%) Close

$ADAG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020
ASSETS
Current assets:
Cash and cash equivalents
Shortterm investments
Accounts receivable, net
Amounts due from related parties
Prepayments and other current assets
Total current assets

Property, equipment and software, net
Operating lease right-of-use assets
Other non-current assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable
Contract liabilities
Amounts due to related parties
Accruals and other current liabilities
Income tax payable
Warrant liabilities
Short-term borrowings
Current portion of long-term borrowings
Current portion of operating lease liabilities
Total current liabilities
Long-term borrowings
Other noncurrent liabilities
Operating lease liabilities
Deferred tax liabilities
Other non-current liabilities
TOTAL LIABILITIES
Series A non-voting contingently redeemable convertible preferred shares (par value of US$0.0001 per share; nil authorized, issued and outstanding as of December 31, 2024; and 1,062,500 shares authorized, issued and outstanding as of December 31, 2025)
Series A-1 convertible redeemable preferred shares
Series A-2 convertible redeemable preferred shares
Series B convertible redeemable preferred shares
Series C-1 convertible redeemable preferred shares
Series C-2 convertible redeemable preferred shares
Series C-3 convertible redeemable preferred shares
Total series A non-voting contingently redeemable convertible preferred shares (par value of US$0.0001 per share; nil authorized, issued and outstanding as of December 31, 2024; and 1,062,500 shares authorized, issued and outstanding as of December 31, 2025)

Shareholders' equity:
Ordinary shares (par value of US$0.0001 per share; 640,000,000 shares authorized, and 58,886,944 shares issued and outstanding as of December 31, 2024; and 640,000,000 shares authorized, and 59,231,993 shares issued and outstanding as of December 31, 2025)
Treasury shares, at cost (Nil and 94,074 shares as of December 31, 2020 and 2021, respectively)
Subscriptions receivable from shareholders
Treasury shares, at cost (1 share as of December 31, 2023 and nil as of December 31, 2024)
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders' equity

TOTAL LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY

Comments